Following the demonstration that JNK blockade could suppress renal fibrosis (Ma et al., 2007a), JNK inhibitors have been shown to alleviate fibrosis in lung disease (van der Velden et al., 2016) and liver disease (Gautheron et al., 2014). The gene discussed is MAPK8; the disease is renal fibrosis.